Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (34)

2024

  1. Impact of age on the outcomes of Takotsubo syndrome

    Cardiovascular Revascularization Medicine, Vol. 61, pp. 44-51

2023

  1. Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 503-510

  2. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  3. Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217

  4. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2022

  1. Bioactive or Drug-Eluting Stents in 75 Years or Older Patients: The BIODES-75 Registry

    Cardiovascular Revascularization Medicine, Vol. 42, pp. 114-120

  2. Clinical Implications of the “Broken Line” Angiographic Pattern in Patients With Spontaneous Coronary Artery Dissection

    American Journal of Cardiology, Vol. 185, pp. 1-9

  3. Impact of Successful Chronic Coronary Total Occlusion Recanalization on Recurrence of Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Recipients for Ischemic Cardiomyopathy (VACTO PCI Study)

    Cardiovascular Revascularization Medicine, Vol. 43, pp. 104-111

  4. Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry

    IJC Heart and Vasculature, Vol. 38

  5. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement

    Canadian Journal of Cardiology, Vol. 38, Núm. 1, pp. 102-112

  6. Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation

    American Journal of Cardiology, Vol. 172, pp. 90-97

  7. One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

    PLoS ONE, Vol. 17, Núm. 12 December

  8. Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 4, pp. 638-646

  9. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  10. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation

    Journal of the American College of Cardiology, Vol. 79, Núm. 8, pp. 772-785

2021

  1. Antithrombotic strategies in elderly patients with atrial fibrillation revascularized with drug-eluting stents: PACO-PCI (EPIC-15) registry

    International Journal of Cardiology, Vol. 338, pp. 63-71

  2. Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 927-937

  3. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

    Cardiovascular Diabetology, Vol. 20, Núm. 1

  4. Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol

    PLoS ONE, Vol. 16, Núm. 7 July

  5. Outcomes of nonagenarians after transcatheter aortic valve implantation

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 250-257